Skip to main content

Table 2 Comparisons of the clinicopathologic features between classical adenocarcinoma and other histologic types, including mucinous adenocarcinoma, signet-ring cell carcinoma and adenocarcinoma with mixed subtypes

From: Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer

Characteristics (N)

Classical adenocarcinoma N (%)

Mucinous adenocarcinoma N (%)

P1a

P2a

Signet-ring cell carcinoma N (%)

P1a

P2a

Adenocarcinoma with mixed subtypes N (%)

P1a

Gender

  

<  0.001

0.05

 

0.11

0.33

 

0.89

Male

8511 (53.8)

2759 (48.5)

  

415 (51.0)

  

175 (54.2)

 

Female

7301 (46.2)

2930 (51.5)

  

399 (49.0)

  

147 (45.8)

 

Age (yrs, median: 66)

  

<  0.001

0.59

 

0.53

0.06

 

0.07

≤ 66

8894 (56.2)

2818 (49.5)

  

467 (57.4)

  

164 (54.5)

 

>  66

6918 (43.8)

2871 (50.5)

  

347 (42.6)

  

157 (45.5)

 

Tumor location

  

<  0.001

0.29

 

<  0.001

0.76

 

<  0.001

Colon

12,198 (77.1)

5055 (88.9)

  

713 (87.6)

  

279 (86.9)

 

Rectum

3614 (22.9)

634 (11.1)

  

101 (12.4)

  

42 (13.1)

 

Grade

  

<  0.001

<  0.001

 

<  0.001

<  0.001

 

<  0.001

Well differentiated

2308 (17.6)

705 (13.4)

  

8 (1.1)

  

4 (1.4)

 

Moderately differentiated

9491 (72.6)

3344 (63.7)

  

58 (8.0)

  

53 (18.0)

 

Poorly differentiated or undifferentiated

1278 (9.8)

1199 (22.8)

  

656 (90.9

  

237 (80.6)

 

Primary tumor size (cm)

  

<  0.001

0.76

 

<  0.001

0.48

 

<  0.001

≤ 4

7754 (71.7)

1628 (31.3)

  

223 (32.8)

  

89 (30.5)

 

>  4

3148 (28.9)

3568 (68.7)

  

457 (67.2)

  

203 (69.5)

 

CEA

  

<  0.001

0.06

 

<  0.001

0.52

 

<  0.001

Normal

4804 (69.9)

1558 (46.4)

  

217 (42.4)

  

76 (39.2)

 

Borderline

25 (0.4)

29 (0.9)

  

3 (0.6)

  

3 (1.5)

 

Elevated

2043 (29.7)

1770 (52.7)

  

292 (57.0)

  

115 (59.3)

 

T category

  

<  0.001

<  0.001

 

<  0.001

0.29

 

<  0.001

Tis

1988 (12.6)

21 (0.4)

  

4 (0.5)

  

0 (0.0)

 

T1

7516 (47.5)

309 (5.4)

  

45 (5.5)

  

11 (3.4)

 

T2

2168 (13.7)

547 (9.6)

  

34 (4.2)

  

21 (6.5)

 

T3

3316 (21.0)

3120 (55.0)

  

341 (42.0)

  

150 (46.7)

 

T4

822 (5.2)

1680 (29.6)

  

388 (47.8)

  

139 (43.3)

 

N category

  

<  0.001

<  0.001

 

<  0.001

0.27

 

<  0.001

N0

12,776 (80.8)

3130 (55.0)

  

251 (30.8)

  

110 (34.3)

 

N1

2244 (14.2)

1405 (24.7)

  

176 (21.6)

  

68 (21.2)

 

N2

792 (5.0)

1154 (20.3)

  

387 (47.5)

  

143 (44.5)

 

M category

  

<  0.001

0.002

 

<  0.001

0.01

 

<  0.001

M0

14,931 (94.4)

4505 (79.2)

  

519 (63.8)

  

231 (72.0)

 

M1

881 (5.6)

1184 (20.8)

  

295 (36.2)

  

90 (28.0)

 

CRM

  

<  0.001

<  0.001

 

<  0.001

0.60

 

<  0.001

Negative

5685 (85.7)

2163 (73.7)

  

220 (62.1)

  

101 (59.8)

 

Positive

950 (14.3)

770 (26.3)

  

134 (37.9)

  

68 (40.2)

 

Perineural invasion

  

<  0.001

<  0.001

 

<  0.001

0.003

 

<  0.001

Negative

12,234 (95.6)

3957 (89.7)

  

383 (70.8)

  

201 (80.7)

 

Positive

569 (4.4)

454 (10.3)

  

158 (29.2)

  

48 (19.3)

 

Tumor deposits

  

<  0.001

<  0.001

 

<  0.001

0.21

 

<  0.001

Absent

12,369 (95.2)

4161 (84.1)

  

421 (67.5)

  

197 (71.6)

 

Present

622 (4.8)

786 (15.9)

  

203 (32.5)

  

78 (28.4)

 
  1. Abbreviation: CEA carcinoembryonic antigen, CRM circumferential resection margin
  2. a P1, comparisons using “classical adenocarcinoma” as the reference. P2, comparisons using “adenocarcinoma with mixed subtypes” as the reference